Clonal Structure, Extended-Spectrum β-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four Countries
暂无分享,去创建一个
H. Goossens | C. Brun-Buisson | Y. Carmeli | W. Hryniewicz | C. Lammens | S. Malhotra-Kumar | M. Paul | M. Gniadkowski | J. Vidal Samsó | A. Salvia | C. Lawrence | J. Fiett | Y. Lerman | A. Adler | A. Baraniak | R. Izdebski | M. Kazma | J. Salomon | A. Rossini | A. Salvia | J. Fierro | J. V. Samsó | Christian Brun-Buisson | Herman Goossens | W. Hryniewicz | Joshua A. Salomon | Angelo Rossini | Christine Lawrence | Mical Paul | S. Malhotra-Kumar
[1] H. Goossens,et al. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] H. Goossens,et al. Characterization of Two New CTX-M-25-Group Extended-Spectrum β-Lactamase Variants Identified in Escherichia coli Isolates from Israel , 2012, PloS one.
[3] N. Woodford,et al. Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. , 2012, The Journal of antimicrobial chemotherapy.
[4] A. Boudabous,et al. Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia , 2012, European Journal of Clinical Microbiology & Infectious Diseases.
[5] I. Luzzi,et al. Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. , 2012, The Journal of antimicrobial chemotherapy.
[6] A. Robicsek,et al. Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009 , 2012, Emerging infectious diseases.
[7] G. Peirano,et al. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. , 2012, Diagnostic microbiology and infectious disease.
[8] J. Quinn,et al. Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009 , 2012, Antimicrobial Agents and Chemotherapy.
[9] J. Cheesbrough,et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. , 2012, The Journal of antimicrobial chemotherapy.
[10] G. Peirano,et al. Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian Region , 2011, Journal of Clinical Microbiology.
[11] J. Blanco,et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. , 2011, The Journal of antimicrobial chemotherapy.
[12] N. Woodford,et al. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. , 2011, The Journal of antimicrobial chemotherapy.
[13] N. Woodford,et al. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. , 2011, FEMS microbiology reviews.
[14] P. Nordmann,et al. When Carbapenem-Hydrolyzing β-Lactamase KPC Meets Escherichia coli ST131 in France , 2011, Antimicrobial Agents and Chemotherapy.
[15] G. Peirano,et al. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[16] G. Peirano,et al. Clinical and Molecular Characteristics of Extended-Spectrum- β-Lactamase-Producing Escherichia coli Causing Bacteremia in the Rotterdam Area, Netherlands , 2011, Antimicrobial Agents and Chemotherapy.
[17] J. Klena,et al. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. , 2011, Microbial drug resistance.
[18] J. Blanco,et al. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). , 2011, The Journal of antimicrobial chemotherapy.
[19] J. Hrabák,et al. DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. , 2010, Microbial drug resistance.
[20] A. Carattoli,et al. Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[21] J. Campos,et al. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact , 2010 .
[22] R. Moreau,et al. Genetic Diversity and Virulence Profiles of Escherichia coli Isolates Causing Spontaneous Bacterial Peritonitis and Bacteremia in Patients with Cirrhosis , 2010, Journal of Clinical Microbiology.
[23] Richard J. Reid-Smith,et al. Food Reservoir for Escherichia coli Causing Urinary Tract Infections , 2010, Emerging infectious diseases.
[24] E. Denamur,et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. , 2009, The Journal of antimicrobial chemotherapy.
[25] J. Campos,et al. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. , 2009, International journal of antimicrobial agents.
[26] P. Barrow,et al. Enterobacteriaceae , 2008, Poultry Diseases.
[27] M. Kuskowski,et al. Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004 , 2009, Antimicrobial Agents and Chemotherapy.
[28] Alessandra Carattoli,et al. Resistance Plasmid Families in Enterobacteriaceae , 2009, Antimicrobial Agents and Chemotherapy.
[29] George A. Jacoby,et al. AmpC β-Lactamases , 2009, Clinical Microbiology Reviews.
[30] M. Kaufmann,et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. , 2008, The Journal of antimicrobial chemotherapy.
[31] Y. Arakawa,et al. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. , 2008, The Journal of antimicrobial chemotherapy.
[32] L. Guize,et al. Absence of CTX-M Enzymes but High Prevalence of Clones, Including Clone ST131, among Fecal Escherichia coli Isolates from Healthy Subjects Living in the Area of Paris, France , 2008, Journal of Clinical Microbiology.
[33] Y. Carmeli,et al. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. , 2008, The Journal of antimicrobial chemotherapy.
[34] A. Marchese,et al. European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis , 2008, Journal of Clinical Microbiology.
[35] E. Sadowy,et al. Molecular Survey of β-Lactamases Conferring Resistance to Newer β-Lactams in Enterobacteriaceae Isolates from Polish Hospitals , 2008, Antimicrobial Agents and Chemotherapy.
[36] K. Laupland,et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .
[37] F. Baquero,et al. Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.
[38] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[39] N. Woodford,et al. CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.
[40] G. Rossolini,et al. CTX-M-Type Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide Problem , 2006, Antimicrobial Agents and Chemotherapy.
[41] Daniel Falush,et al. Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.
[42] D. Livermore,et al. CTX-M: changing the face of ESBLs in the UK. , 2005, The Journal of antimicrobial chemotherapy.
[43] E. Sadowy,et al. Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland , 2004, Antimicrobial Agents and Chemotherapy.
[44] N. Hanson,et al. Detection of Plasmid-Mediated AmpC β-Lactamase Genes in Clinical Isolates by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.
[45] Gregor Tanner,et al. Determining Confidence Intervals When Measuring Genetic Diversity and the Discriminatory Abilities of Typing Methods for Microorganisms , 2001, Journal of Clinical Microbiology.
[46] P. Bradford. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.
[47] R. Bonnet,et al. A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in France , 2000, Antimicrobial Agents and Chemotherapy.
[48] O. Clermont,et al. Rapid and Simple Determination of theEscherichia coli Phylogenetic Group , 2000, Applied and Environmental Microbiology.
[49] D. F. Sahm,et al. AmpC beta-lactamases. , 1998 .
[50] D H Persing,et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.
[51] M. Struelens,et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. , 1993, The American journal of medicine.
[52] A. Bauernfeind,et al. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli , 1990, Infection.
[53] D. Paterson,et al. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. , 2011, The Journal of antimicrobial chemotherapy.
[54] V. Jarlier,et al. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[55] G. Rossolini,et al. The spread of CTX-M-type extended-spectrum β-lactamases , 2008 .
[56] N. Woodford,et al. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. , 2006, The Journal of antimicrobial chemotherapy.